Fund Holdings — CAXTON CORP

Total Portfolio Value:
$5.08M
Total Bought:
$91.0K
Total Sold:
$8.80M
Net Transaction:
-$8.71M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Rezolute, Inc.(RZLT)1,318,9671,318,9670$6.46M$3.83M75.28%-$2.64M
SPDR Gold SharesGOLD SHS(GLD)1,1691,298+129$283.1K$374.1K7.36%+$91.0K
Berkshire Hathaway Inc DelCL B1,133467-666$513.6K$248.8K4.90%-$264.7K
Mind Medicine Mindmed Inc34,07334,0730$237.1K$199.3K3.92%-$37.8K
Bicara Therapeutics Inc10,94110,9410$190.6K$142.6K2.81%-$48.0K
Compass Therapeutics, Inc.(CMPX)43,46543,4650$63.0K$82.6K1.63%+$19.6K
Lexeo Therapeutics, Inc.(LXEO)17,85117,8510$117.5K$61.9K1.22%-$55.5K
Kyverna Therapeutics, Inc.(KYTX)22,98122,9810$86.0K$44.4K0.87%-$41.6K
Cardiff Oncology, Inc.(CRDF)13,28713,2870$57.7K$41.7K0.82%-$15.9K
Inhibikase Therapeutics, Inc.(IKT)16,39316,3930$53.3K$35.9K0.71%-$17.4K
Adicet Bio Inc17,48817,4880$16.8K$13.2K0.26%-$3.6K
Context Therapeutics Inc.(CNTX)18,40318,4030$19.3K$11.3K0.22%-$8.1K
Glycomimetics Inc203,5780-203,578$50.9K$0—-$50.9K
State Street SPDR S&P 500 ETF TrustTR UNIT(SPY)2,8230-2,823$1.65M$0—-$1.65M
Xeris Biopharma Holdings Inc2,015,1570-2,015,157$6.83M$0—-$6.83M
Page 1 of 1
CAXTON CORP — 13F Holdings — Q1 2025 | TickerTrail